CoChat

Platelets in aging and cancer—“double-edged sword”

Open access
Faria, Alessandra V. S., Andrade, Sheila S., Peppelenbosch, Maikel P., Ferreira-Halder, Carmen V., Fuhler, Gwenny M. · 2020 · Cancer and Metastasis Reviews

The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.

Abstract

Platelets control hemostasis and play a key role in inflammation and immunity. However, platelet function may change during aging, and a role for these versatile cells in many age-related pathological processes is emerging. In addition to a well-known role in cardiovascular disease, platelet activity is now thought to contribute to cancer cell metastasis and tumor-associated venous thromboembolism (VTE) development. Worldwide, the great majority of all patients with cardiovascular disease and some with cancer receive anti-platelet therapy to reduce the risk of thrombosis. However, not only do thrombotic diseases remain a leading cause of morbidity and mortality, cancer, especially metastasis, is still the second cause of death worldwide. Understanding how platelets change during aging and how they may contribute to aging-related diseases such as cancer may contribute to steps taken along the road towards a “healthy aging” strategy. Here, we review the changes that occur in platelets during aging, and investigate how these versatile blood components contribute to cancer progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10555-020-09926-2

Cites

192 of 192 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Age-associated changes in platelet function. Platelet function of aggregation, tissue repair, and remodeling changes discriminated on age groups. The concept of age groups is based on young adults (18–39 years), middle-aged (40–59 years), old-aged (60–79 years), very-old-aged group (> 80 years) [27, 29]
Fig. 1 Age-associated changes in platelet function. Platelet function of aggregation, tissue repair, and remodeling changes discriminated on age groups. The concept of age groups is based on young adults (18–39 years), middle-aged (40–59 years), old-aged (60–79 years), very-old-aged group (> 80 years) [27, 29]CC BY · PubMed Central
Fig. 2 Age-associated changed in platelet markers. Platelets present several changes during the aging process on their content (cytosolic and membrane) and release thereof. The concept of age groups is based on young adults (18–39 years), middle-aged (40–59 years), old-aged (60–79 years), very-old-aged group (>80 years) [40–47, 31, 32, 48, 58]
Fig. 2 Age-associated changed in platelet markers. Platelets present several changes during the aging process on their content (cytosolic and membrane) and release thereof. The concept of age groups is based on young adults (18–39 years), middle-aged (40–59 years), old-aged (60–79 years), very-old-aged group (>80 years) [40–47, 31, 32, 48, 58]CC BY · PubMed Central
Fig. 3 The cross talk between cancer cells and platelets support metastasis, angiogenesis, and tumor growth. Platelets release factors such as TGFβ and VEGF that stimulate epithelial-to-mesenchymal transition (EMT) and angiogenesis. Additionally, platelets contribute to escape from immunosurveillance by covering cancer cells and shielding them from the immune system
Fig. 3 The cross talk between cancer cells and platelets support metastasis, angiogenesis, and tumor growth. Platelets release factors such as TGFβ and VEGF that stimulate epithelial-to-mesenchymal transition (EMT) and angiogenesis. Additionally, platelets contribute to escape from immunosurveillance by covering cancer cells and shielding them from the immune systemCC BY · PubMed Central
Fig. 4 Aging-related changes in platelet function and their association with aging-related diseases (e.g., cancer). As a cross-link between aging and cancer, oxidative stress, wound healing disturbed, inflammation, lower platelet count, and senescent cells delivery factors are highlighted. Platelets support metastasis by augmentation of integrin activity, increasing expression of metalloproteinases, and the release of growth factors, which also augment angiogenesis. Furthermore, kinase activation, including mTOR pathways, increase platelet activation. Production of reactive oxygen species enhances platelet production
Fig. 4 Aging-related changes in platelet function and their association with aging-related diseases (e.g., cancer). As a cross-link between aging and cancer, oxidative stress, wound healing disturbed, inflammation, lower platelet count, and senescent cells delivery factors are highlighted. Platelets support metastasis by augmentation of integrin activity, increasing expression of metalloproteinases, and the release of growth factors, which also augment angiogenesis. Furthermore, kinase activation, including mTOR pathways, increase platelet activation. Production of reactive oxygen species enhances platelet productionCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 192 references

Cited by

See all 38

Metadata

Authors
Faria, A. V. S., Andrade, S. S., Peppelenbosch, M. P., Ferreira-Halder, C. V., & Fuhler, G. M.
Affiliations
Erasmus MC (NL)
Corresponding author
Fuhler, Gwenny M.
Venue
Cancer and Metastasis Reviews
Published
2020-09-01
Volume
39
Issue
4
Pages
1205-1221
ISSN
  • 0167-7659 (ISSN-L)
  • 1573-7233
OpenAlex
W3082483189
Cited by
38
References
191
Citations by year
2026: 3 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 3 · 2020: 2
FWCI
0.71
Type
journal article
Language
en
Open access
Licence
Locations
  • Cancer and Metastasis Reviews (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Funders
Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/08119-8, 2018/00736-0, 2016/14459-3, 2017/26317-1, 2015/20412-7)
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
platelets, aging, cancer, platelet function, hemostasis, inflammation, metastasis, antiplatelet therapy, thrombosis, healthy aging
MeSH terms
Age Factors, Animals, Blood Platelets, Humans, Neoplasms, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Platelets in aging and cancer—“double-edged sword”. https://app.cochat.ai/papers/10.1007/s10555-020-09926-2
The paper
Faria, A. V. S., Andrade, S. S., Peppelenbosch, M. P., Ferreira-Halder, C. V., & Fuhler, G. M. (2020). Platelets in aging and cancer—“double-edged sword”. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-020-09926-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.